Aurobindo Pharma Limited has informed the Exchange regarding a press release dated December 05, 2024, titled "Press Release - Eugia Pharma receives USFDA approval for Pazopanib Tablets, 200 mg".
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated December 05, 2024, titled "Press Release - Eugia Pharma receives USFDA approval for Pazopanib Tablets, 200 mg".